Teva Pharmaceuticals USA, Inc 2025-02-12 Health serious FDA
Health · FDA · Recall #FDA-D-0218-2025
Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged… Recall
Issued February 12, 2025 · Teva Pharmaceuticals USA, Inc
In February 2025, Teva Pharmaceuticals USA, Inc recalled the Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
What you should do
- 1 Stop using Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Teva Pharmaceuticals USA, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Teva Pharmaceuticals USA, Inc
- Category
- Health
- Recall date
- February 12, 2025
- Units affected
- Not reported
- Sold at
- Product was distributed nationwide.
- Recall number
- FDA-D-0218-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Teva Pharmaceuticals USA, Inc has 13 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.